Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_3
3
75%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (75.0%)
Phase 41 (25.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

NCT00249873
completedphase_4

Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

NCT00386191
terminatedphase_3

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

NCT00243178
completedphase_3

Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation

NCT00325390

Clinical Trials (4)

Showing 4 of 4 trials
NCT00249873Phase 3

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Completed
NCT00386191Phase 4

Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

Completed
NCT00243178Phase 3

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

Terminated
NCT00325390Phase 3

Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4